Cargando…

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors

OBJECTIVE: Pleural effusion (PE) is a common feature of malignant pleural mesothelioma. These effusions typically contain lymphocytes and malignant cells. We postulated that the PE would be a source of lymphocytes for analysis of tumor immune milieu. The aim of this study was to compare the phenotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chee, Jonathan, Watson, Mark W., Chopra, Abha, Nguyen, Bella, Cook, Alistair M., Creaney, Jenette, Lesterhuis, Willem J., Robinson, Bruce W., Lee, Y. C. Gary, Nowak, Anna K., Lake, Richard A., McDonnell, Alison M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282254/
https://www.ncbi.nlm.nih.gov/pubmed/30518402
http://dx.doi.org/10.1186/s13104-018-3953-x
_version_ 1783378951289176064
author Chee, Jonathan
Watson, Mark W.
Chopra, Abha
Nguyen, Bella
Cook, Alistair M.
Creaney, Jenette
Lesterhuis, Willem J.
Robinson, Bruce W.
Lee, Y. C. Gary
Nowak, Anna K.
Lake, Richard A.
McDonnell, Alison M.
author_facet Chee, Jonathan
Watson, Mark W.
Chopra, Abha
Nguyen, Bella
Cook, Alistair M.
Creaney, Jenette
Lesterhuis, Willem J.
Robinson, Bruce W.
Lee, Y. C. Gary
Nowak, Anna K.
Lake, Richard A.
McDonnell, Alison M.
author_sort Chee, Jonathan
collection PubMed
description OBJECTIVE: Pleural effusion (PE) is a common feature of malignant pleural mesothelioma. These effusions typically contain lymphocytes and malignant cells. We postulated that the PE would be a source of lymphocytes for analysis of tumor immune milieu. The aim of this study was to compare the phenotype and T cell receptor usage of pleural effusion T cells with paired concurrently drawn peripheral blood lymphocytes. We used multi-parameter flow cytometry and high-throughput T cell receptor sequencing to analyse peripheral blood and pleural effusion mononuclear cells. RESULTS: Both CD8(+) and CD4(+) T cells from effusion showed increased expression of T cell inhibitory receptors PD-1, LAG-3 and Tim-3 compared to blood. Comprehensive T cell receptor sequencing on one of the patients showed a discordant distribution of clonotypes in the antigen-experienced (PD-1(+)) compartment between effusion and blood, suggesting an enrichment of antigen specific clonotypes in the effusion, with potential as an immunological response biomarker.
format Online
Article
Text
id pubmed-6282254
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62822542018-12-10 Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors Chee, Jonathan Watson, Mark W. Chopra, Abha Nguyen, Bella Cook, Alistair M. Creaney, Jenette Lesterhuis, Willem J. Robinson, Bruce W. Lee, Y. C. Gary Nowak, Anna K. Lake, Richard A. McDonnell, Alison M. BMC Res Notes Research Note OBJECTIVE: Pleural effusion (PE) is a common feature of malignant pleural mesothelioma. These effusions typically contain lymphocytes and malignant cells. We postulated that the PE would be a source of lymphocytes for analysis of tumor immune milieu. The aim of this study was to compare the phenotype and T cell receptor usage of pleural effusion T cells with paired concurrently drawn peripheral blood lymphocytes. We used multi-parameter flow cytometry and high-throughput T cell receptor sequencing to analyse peripheral blood and pleural effusion mononuclear cells. RESULTS: Both CD8(+) and CD4(+) T cells from effusion showed increased expression of T cell inhibitory receptors PD-1, LAG-3 and Tim-3 compared to blood. Comprehensive T cell receptor sequencing on one of the patients showed a discordant distribution of clonotypes in the antigen-experienced (PD-1(+)) compartment between effusion and blood, suggesting an enrichment of antigen specific clonotypes in the effusion, with potential as an immunological response biomarker. BioMed Central 2018-12-05 /pmc/articles/PMC6282254/ /pubmed/30518402 http://dx.doi.org/10.1186/s13104-018-3953-x Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Chee, Jonathan
Watson, Mark W.
Chopra, Abha
Nguyen, Bella
Cook, Alistair M.
Creaney, Jenette
Lesterhuis, Willem J.
Robinson, Bruce W.
Lee, Y. C. Gary
Nowak, Anna K.
Lake, Richard A.
McDonnell, Alison M.
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
title Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
title_full Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
title_fullStr Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
title_full_unstemmed Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
title_short Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
title_sort tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282254/
https://www.ncbi.nlm.nih.gov/pubmed/30518402
http://dx.doi.org/10.1186/s13104-018-3953-x
work_keys_str_mv AT cheejonathan tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT watsonmarkw tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT chopraabha tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT nguyenbella tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT cookalistairm tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT creaneyjenette tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT lesterhuiswillemj tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT robinsonbrucew tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT leeycgary tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT nowakannak tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT lakericharda tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors
AT mcdonnellalisonm tumourassociatedlymphocytesinthepleuraleffusionsofpatientswithmesotheliomaexpresshighlevelsofinhibitoryreceptors